PTP1B is a negative regulator of interleukin 4-induced STAT6 signaling.

Blood
Xiaoqing LuIzidore S Lossos

Abstract

Protein tyrosine phosphatase 1B (PTP1B) is a ubiquitously expressed enzyme shown to negatively regulate multiple tyrosine phosphorylation-dependent signaling pathways. PTP1B can modulate cytokine signaling pathways by dephosphorylating JAK2, TYK2, and STAT5a/b. Herein, we report that phosphorylated STAT6 may serve as a cytoplasmic substrate for PTP1B. Overexpression of PTP1B led to STAT6 dephosphorylation and the suppression of STAT6 transcriptional activity, whereas PTP1B knockdown or deficiency augmented IL-4-induced STAT6 signaling. Pretreatment of these cells with the PTK inhibitor staurosporine led to sustained STAT6 phosphorylation consistent with STAT6 serving as a direct substrate of PTP1B. Furthermore, PTP1B-D181A "substrate-trapping" mutants formed stable complexes with phosphorylated STAT6 in a cellular context and endogenous PTP1B and STAT6 interacted in an interleukin 4 (IL-4)-inducible manner. We delineate a new negative regulatory loop of IL-4-JAK-STAT6 signaling. We demonstrate that IL-4 induces PTP1B mRNA expression in a phosphatidylinositol 3-kinase-dependent manner and enhances PTP1B protein stability to suppress IL-4-induced STAT6 signaling. Finally, we show that PTP1B expression may be preferentially elevat...Continue Reading

References

Oct 1, 1996·Molecular and Cellular Biology·T MikitaU Schindler
Mar 4, 1997·Proceedings of the National Academy of Sciences of the United States of America·A J FlintN K Tonks
Jan 16, 1999·Advances in Experimental Medicine and Biology·K NelmsW E Paul
Nov 6, 2001·The Journal of Biological Chemistry·M P MyersN K Tonks
Mar 23, 2002·Current Biology : CB·Paul D SimoncicC Jane McGlade
Apr 24, 2002·Developmental Cell·Alan ChengMichel L Tremblay
Jun 21, 2002·The New England Journal of Medicine·Andreas RosenwaldUNKNOWN Lymphoma/Leukemia Molecular Profiling Project
Jul 26, 2002·Molecular and Cellular Biology·Johanna ten HoeveKe Shuai
Nov 9, 2002·The Journal of Biological Chemistry·Fawaz G HajBenjamin G Neel
May 16, 2003·Molecular and Cellular Biology·Feng GuYves R Boisclair
Aug 6, 2003·Proceedings of the National Academy of Sciences of the United States of America·George WrightLouis M Staudt
Dec 12, 2003·Nature Reviews. Immunology·Ke Shuai, Bin Liu
Jan 6, 2005·Molecular and Cellular Biology·Sandra GalicTony Tiganis
Feb 25, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Stephen CanfieldPaul Rothman
Feb 16, 2006·Proceedings of the National Academy of Sciences of the United States of America·Krista M HeinonenMichel L Tremblay
Sep 26, 2006·Canadian Journal of Physiology and Pharmacology·Paul D SimoncicMichel L Tremblay
Jan 24, 2007·The Biochemical Journal·Tony Tiganis, Anton M Bennett
Dec 19, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Yasodha NatkunamIzidore S Lossos
Feb 19, 2008·The Journal of Biological Chemistry·Janice M ZabolotnyBarbara B Kahn

❮ Previous
Next ❯

Citations

Dec 18, 2012·Breast Cancer Research and Treatment·S SoysalS Muenst
Dec 24, 2010·Nature Reviews. Cancer·Sofi G JulienMichel L Tremblay
Nov 7, 2012·Proceedings of the National Academy of Sciences of the United States of America·Christopher J CarboneSerge Y Fuchs
Apr 12, 2012·The Journal of Biological Chemistry·Inmaculada García-RuizJosé A Solís-Herruzo
Mar 24, 2012·Molecular & Cellular Proteomics : MCP·Sally J DeebMatthias Mann
Mar 3, 2010·Annual Review of Immunology·Jinfang ZhuWilliam E Paul
Jan 26, 2013·The Journal of Clinical Investigation·Ellen H van den BogaardJoost Schalkwijk
Jul 30, 2014·Archives of Biochemistry and Biophysics·Muhammad Nauman AftabRanjan J Perera
Mar 25, 2014·Expert Opinion on Therapeutic Targets·Yan LiangDong-Qing Ye
Sep 19, 2009·Expert Review of Anticancer Therapy·Javier Briones
Jul 25, 2013·Critical Reviews in Biochemistry and Molecular Biology·Matthew FeldhammerMichel L Tremblay
Jan 29, 2016·Cytokine·Kelly A Pike, Michel L Tremblay
Oct 18, 2011·Seminars in Hematology·Vinai C BhagirathMark A Crowther
Dec 31, 2015·Pathology Oncology Research : POR·Baoying HuTianyi Zhang
Jul 28, 2010·Biochimica Et Biophysica Acta·Roberta R Ruela-de-SousaGwenny M Fuhler
Jul 16, 2010·Blood Cells, Molecules & Diseases·Alexander BrobeilMonika Wimmer
Aug 25, 2009·Best Practice & Research. Clinical Haematology·Javeed IqbalWing C Chan
Jun 25, 2014·Proceedings of the National Academy of Sciences of the United States of America·Haydn T KissickMohamed S Arredouani
Jul 15, 2011·British Journal of Clinical Pharmacology·Rashid S Kazmi, Bashir A Lwaleed
Jul 29, 2015·Seminars in Immunology·Lisa K Kozicky, Laura M Sly
Sep 29, 2009·Biochimica Et Biophysica Acta·Laurent LessardMichel L Tremblay
Apr 21, 2016·Journal of Neuroinflammation·Gyun Jee SongKyoungho Suk
Apr 30, 2014·JAK-STAT·Frank-D Böhmer, Karlheinz Friedrich
Mar 26, 2015·Seminars in Hematology·Kieron Dunleavy, Christian Steidl
Nov 13, 2015·PLoS Computational Biology·Gaurav DwivediMelissa L Kemp
Jul 16, 2016·The Journal of Allergy and Clinical Immunology·Sara L HallIan P Lewkowich

❮ Previous
Next ❯

Related Concepts

Related Feeds

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.